rs2067481

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001375978.1(CHRM3):​c.193G>A​(p.Val65Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0156 in 1,614,116 control chromosomes in the GnomAD database, including 287 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 28 hom., cov: 32)
Exomes 𝑓: 0.016 ( 259 hom. )

Consequence

CHRM3
NM_001375978.1 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0850

Publications

13 publications found
Variant links:
Genes affected
CHRM3 (HGNC:1952): (cholinergic receptor muscarinic 3) The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 3 controls smooth muscle contraction and its stimulation causes secretion of glandular tissue. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
CHRM3-AS1 (HGNC:40150): (CHRM3 antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001375978.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00343284).
BP6
Variant 1-239907644-G-A is Benign according to our data. Variant chr1-239907644-G-A is described in ClinVar as Benign. ClinVar VariationId is 1576872.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0135 (2055/152230) while in subpopulation SAS AF = 0.0375 (181/4824). AF 95% confidence interval is 0.0331. There are 28 homozygotes in GnomAd4. There are 1103 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001375978.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRM3
NM_001375978.1
MANE Select
c.193G>Ap.Val65Ile
missense
Exon 7 of 7NP_001362907.1P20309
CHRM3
NM_000740.4
c.193G>Ap.Val65Ile
missense
Exon 5 of 5NP_000731.1P20309
CHRM3
NM_001347716.2
c.193G>Ap.Val65Ile
missense
Exon 8 of 8NP_001334645.1P20309

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRM3
ENST00000676153.1
MANE Select
c.193G>Ap.Val65Ile
missense
Exon 7 of 7ENSP00000502667.1P20309
CHRM3
ENST00000255380.8
TSL:1
c.193G>Ap.Val65Ile
missense
Exon 5 of 5ENSP00000255380.4P20309
CHRM3
ENST00000615928.5
TSL:5
c.193G>Ap.Val65Ile
missense
Exon 6 of 6ENSP00000482377.1P20309

Frequencies

GnomAD3 genomes
AF:
0.0135
AC:
2054
AN:
152112
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00576
Gnomad ASJ
AF:
0.00837
Gnomad EAS
AF:
0.00521
Gnomad SAS
AF:
0.0373
Gnomad FIN
AF:
0.0455
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0162
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.0174
AC:
4386
AN:
251400
AF XY:
0.0197
show subpopulations
Gnomad AFR exome
AF:
0.00228
Gnomad AMR exome
AF:
0.00419
Gnomad ASJ exome
AF:
0.00804
Gnomad EAS exome
AF:
0.00348
Gnomad FIN exome
AF:
0.0431
Gnomad NFE exome
AF:
0.0155
Gnomad OTH exome
AF:
0.0157
GnomAD4 exome
AF:
0.0158
AC:
23099
AN:
1461886
Hom.:
259
Cov.:
31
AF XY:
0.0168
AC XY:
12200
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00230
AC:
77
AN:
33480
American (AMR)
AF:
0.00458
AC:
205
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00872
AC:
228
AN:
26136
East Asian (EAS)
AF:
0.00202
AC:
80
AN:
39698
South Asian (SAS)
AF:
0.0431
AC:
3716
AN:
86258
European-Finnish (FIN)
AF:
0.0421
AC:
2247
AN:
53420
Middle Eastern (MID)
AF:
0.0227
AC:
131
AN:
5768
European-Non Finnish (NFE)
AF:
0.0140
AC:
15541
AN:
1112006
Other (OTH)
AF:
0.0145
AC:
874
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1448
2896
4343
5791
7239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0135
AC:
2055
AN:
152230
Hom.:
28
Cov.:
32
AF XY:
0.0148
AC XY:
1103
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00274
AC:
114
AN:
41544
American (AMR)
AF:
0.00576
AC:
88
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00837
AC:
29
AN:
3466
East Asian (EAS)
AF:
0.00522
AC:
27
AN:
5170
South Asian (SAS)
AF:
0.0375
AC:
181
AN:
4824
European-Finnish (FIN)
AF:
0.0455
AC:
482
AN:
10602
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0162
AC:
1100
AN:
68014
Other (OTH)
AF:
0.0147
AC:
31
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
96
192
289
385
481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0132
Hom.:
67
Bravo
AF:
0.00861
Asia WGS
AF:
0.0140
AC:
49
AN:
3478
EpiCase
AF:
0.0142
EpiControl
AF:
0.0151

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.28
DANN
Benign
0.77
DEOGEN2
Benign
0.060
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.072
N
LIST_S2
Benign
0.70
T
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.085
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.26
N
REVEL
Benign
0.086
Sift
Benign
0.49
T
Sift4G
Benign
0.084
T
Varity_R
0.025
gMVP
0.38
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2067481;
hg19: chr1-240070944;
COSMIC: COSV55091298;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.